Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Blood-derived stable induced neural stem cells: Preservation of age-related DNA methylation patterns and applicability to disease modeling

ABSTRACT: Direct transcription factor-mediated cell fate conversion provides an attractive route for the derivation of patient-specific somatic cells. Here we report on the generation of bona fide induced neural stem cells (iNSCs) from adult peripheral blood and their suitability for modeling late-onset disease. Employing restricted and integration-free expression of the transcription factors SOX2 and c-MYC we generated clonally expandable iNSCs that can proliferate across at least 20 passages, remain highly responsive to regional patterning cues and give rise to functional neurons, astrocytes and oligodendrocytes. Interestingly, and in contrast to pluripotent stem cell-derived neural cells, iNSCs exhibit partial preservation of age-related DNA methylation signatures. Employing the polyglutamine disorder Machado-Joseph disease (MJD) as an exemplar, we demonstrate that MJD iNSC-derived neurons show a striking and specific pathological protein aggregation phenotype. Our findings suggest that iNSCs may provide a particularly attractive resource for modeling late-onset neurological disorders.

ORGANISM(S): Homo sapiens

PROVIDER: GSE90129 | GEO | 2018/11/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

An engineered Sox17 induces somatic to neural stem cell fate transition independently from pluripotency reprogramming [RNA-seq III]

Project description:Advances in molecular strategies to reprogram cell fate is a promising avenue for cell-based therapies. Methods to generate induced neural stem cells (iNSCs) are often slow with limited reprogramming events and it is unclear whether cells transit via a pluripotent state. We report an iNSC reprogramming approach from embryonic and aged mouse fibroblasts using an engineered Sox17 (eSox17FNV). eSox17FNV efficiently drives iNSC reprogramming while Sox2 or Sox17 fails to do so. eSox17FNV acquires the capacity to bind new protein partners to scan the genome more efficiently and possesses a more potent transactivation domain than Sox2. At the onset of reprogramming, in the presence of eSox17FNV, fibroblasts divert from a iPSC route towards iNSC fate. Further, lineage tracing shows that emerging iNSCs do not transit through a pluripotent state if POU factors are excluded. This reveals new molecular and physiological framework for iNSC generation and contrasts with lineage from pluripotency reprogramming.

2023-07-19 | GSE225830 | GEO

An engineered Sox17 induces somatic to neural stem cell fate transition independently from pluripotency reprogramming [scRNA-seq]

2023-07-19 | GSE225306 | GEO

An engineered Sox17 induces somatic to neural stem cell fate transition independently from pluripotency reprogramming [RRBS]

2023-07-19 | GSE225305 | GEO

An engineered Sox17 induces somatic to neural stem cell fate transition independently from pluripotency reprogramming [ATAC-Seq]

2023-07-19 | GSE195554 | GEO

An engineered Sox17 induces somatic to neural stem cell fate transition independently from pluripotency reprogramming [RNA-seq]

2023-07-19 | GSE195551 | GEO

An engineered Sox17 induces somatic to neural stem cell fate transition independently from pluripotency reprogramming [RNA-seq II]

2023-07-19 | GSE225829 | GEO

Pluripotency factor-induced lineage conversion involves transient passage through an iPS cell stage

Project description:Brief expression of pluripotency-associated factors such as OCT4, KLF4, SOX2 and c-MYC (OKSM), in combination with differentiation-inducing signals, was reported to trigger transdifferentiation of fibroblasts into alternative cell types. Here, we show that OKSM expression gives rise to both induced pluripotent stem cells (iPSCs) and iNSCs under conditions that were previously shown to induce only NSC transdifferentiation. Fibroblast-derived iNSC colonies silenced retroviral transgenes and reactivated silenced X chromosomes, both hallmarks of pluripotent stem cells. Moreover, lineage tracing via an Oct4-CreER labeling system demonstrated that virtually all iNSC colonies originate from cells transiently expressing Oct4, whereas ablation of Oct4-positive cells prevented iNSC formation. Lastly, use of an alternative transdifferentiation cocktail that lacks OCT4 and was reportedly unable to support induced pluripotency, yielded iPSCs and iNSCs carrying the Oct4-CreER-derived lineage label. Together, these data suggest that iNSC generation using OKSM and related reprogramming factors requires passage through a transient iPSC state. 5 samples were anlyzed in total, 2 induced pluripotent stem cells (iPSCs), 1 neural stem cells (NSCs) and 2 induced NSCs (iNSCs)

2015-04-30 | E-GEOD-65951 | biostudies-arrayexpress

Lineage conversion induced by pluripotency factors involves transient passage through an iPSC stage

Project description:Brief expression of pluripotency-associated factors such as Oct4, Klf4, Sox2 and c-Myc (OKSM), in combination with differentiation-inducing signals, has been reported to trigger transdifferentiation of fibroblasts into other cell types. Here we show that OKSM expression in mouse fibroblasts gives rise to both induced pluripotent stem cells (iPSCs) and induced neural stem cells (iNSCs) under conditions previously shown to induce only iNSCs. Fibroblast-derived iNSC colonies silenced retroviral transgenes and reactivated silenced X chromosomes, both hallmarks of pluripotent stem cells. Moreover, lineage tracing with an Oct4-CreER labeling system demonstrated that virtually all iNSC colonies originated from cells transiently expressing Oct4, whereas ablation of Oct4+ cells prevented iNSC formation. Lastly, an alternative transdifferentiation cocktail that lacks Oct4 and was reportedly unable to support induced pluripotency yielded iPSCs and iNSCs carrying the Oct4-CreER-derived lineage label. Together, these data suggest that iNSC generation from fibroblasts using OKSM and other pluripotency-related reprogramming factors requires passage through a transient iPSC state.

2015-04-30 | GSE65951 | GEO

Deubiquitinase USP13 regulates cardiac hypertrophy and dysfunction

Project description:Construction of transcriptome sequencing library and transcriptome sequencing was completed by LC-Bio Technology Co., Ltd. (Hangzhou, China). The expression profile of Machado-joseph deubiquitinases (MJDs) family in heart tissues of Ang II mice.

2023-12-31 | GSE236650 | GEO

Deubiquitinase JOSD2 improves calcium handling and attenuates cardiac hypertrophy and dysfunction through stabilizing SERCA2a in cardiomyocytes

2023-07-06 | GSE236431 | GEO